ocrelizumab

Breakthrough in MS treatment

Published: 9Jan2017

In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary...

Breakthrough in MS treatment

Published: 22Dec2016

Drug shown to reduce new attacks/symptom progression in some patients...

Back to top